Cultured Therapeutics provides ketamine and psychedelic-assisted therapy to individuals experiencing mental health disorders and chronic pain, with a focus on under-resourced populations. The practice aims to improve access to effective treatment options and integrated wellness solutions through specialized education and compassionate care from board-certified physicians.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals, particularly those in under-resourced communities, lack access to effective mental health and chronic pain treatments. Traditional therapies may not be sufficient for some, and innovative approaches are often inaccessible due to cost, location, or other barriers.
Solution
Cultured Therapeutics offers ketamine and psychedelic-assisted therapy as a treatment option for individuals struggling with mental health disorders and chronic pain. The practice focuses on expanding access to these therapies, especially for under-resourced populations, by providing specialized education and compassionate care. Board-certified physicians administer the treatments within an integrated wellness framework. The goal is to provide effective alternative treatment options and improve overall well-being for patients who have not found relief through conventional methods.
Target Audience
The primary target audience includes individuals experiencing mental health disorders such as depression, anxiety, and PTSD, as well as those suffering from chronic pain, particularly within under-resourced communities.
Features
- Ketamine-assisted therapy for depression, anxiety, PTSD, and other mood disorders
- Psychedelic-assisted therapy using evidence-based protocols
- Integrated wellness solutions including mindfulness practices and lifestyle coaching
- Individualized treatment plans tailored to patient needs and goals
- Telehealth consultations for remote access and convenience
- Specialized education on the benefits and risks of psychedelic therapies